Literature DB >> 16145177

Successful treatment of multidrug-resistant Acinetobacter baumannii central nervous system infections with colistin.

Aspasia Katragkou, Emmanuel Roilides.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16145177      PMCID： PMC1234106          DOI： 10.1128/JCM.43.9.4916-4917.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  13 in total

Review 1.  Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria.

Authors:  M E Evans; D J Feola; R P Rapp
Journal:  Ann Pharmacother       Date:  1999-09       Impact factor: 3.154

2.  Intrathecal use of colistin.

Authors:  W Vasen; P Desmery; S Ilutovich; A Di Martino
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

3.  Successful treatment of multidrug-resistant Acinetobacter baumannii meningitis with intravenous colistin sulfomethate sodium.

Authors:  M E Jiménez-Mejías; B Becerril; F J Márquez-Rivas; C Pichardo; L Cuberos; J Pachón
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2000-12       Impact factor: 3.267

4.  Cerebrospinal fluid penetration and pharmacokinetic/pharmacodynamic parameters of intravenously administered colistin in a case of multidrug-resistant Acinetobacter baumannii meningitis.

Authors:  M E Jiménez-Mejías; C Pichardo-Guerrero; F J Márquez-Rivas; D Martín-Lozano; T Prados; J Pachón
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2002-03-19       Impact factor: 3.267

5.  Successful treatment of Acinetobacter meningitis with intrathecal polymyxin E.

Authors:  Mony Benifla; Gideon Zucker; Avi Cohen; Michael Alkan
Journal:  J Antimicrob Chemother       Date:  2004-06-09       Impact factor: 5.790

6.  Worldwide emergence of carbapenem-resistant Acinetobacter spp.

Authors:  M Afzal-Shah; D M Livermore
Journal:  J Antimicrob Chemother       Date:  1998-05       Impact factor: 5.790

Review 7.  Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features.

Authors:  E Bergogne-Bérézin; K J Towner
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

8.  Use of colistin in the treatment of multiple-drug-resistant gram-negative infections.

Authors:  David Berlana; J M Llop; E Fort; M B Badia; R Jódar
Journal:  Am J Health Syst Pharm       Date:  2005-01-01       Impact factor: 2.637

Review 9.  Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria.

Authors:  Jian Li; Roger L Nation; Robert W Milne; John D Turnidge; Kingsley Coulthard
Journal:  Int J Antimicrob Agents       Date:  2005-01       Impact factor: 5.283

Review 10.  Multidrug-resistant Acinetobacter infections: an emerging challenge to clinicians.

Authors:  Rupali Jain; Larry H Danziger
Journal:  Ann Pharmacother       Date:  2004-07-27       Impact factor: 3.154
View more
  21 in total

1.  Activity of colistin against heteroresistant Acinetobacter baumannii and emergence of resistance in an in vitro pharmacokinetic/pharmacodynamic model.

Authors:  Chun-Hong Tan; Jian Li; Roger L Nation
Journal:  Antimicrob Agents Chemother       Date:  2007-07-09       Impact factor: 5.191

Review 2.  Global challenge of multidrug-resistant Acinetobacter baumannii.

Authors:  Federico Perez; Andrea M Hujer; Kristine M Hujer; Brooke K Decker; Philip N Rather; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2007-07-23       Impact factor: 5.191

3.  Successful treatment of three children with post-neurosurgical multidrug-resistant Acinetobacter baumannii meningitis.

Authors:  H Ozdemir; A Tapisiz; E Ciftçi; E Ince; H Mokhtari; H Güriz; A D Aysev; U Doğru
Journal:  Infection       Date:  2010-04-01       Impact factor: 3.553

4.  Bacterial meningitis in older adults.

Authors:  Diedre Hofinger; Larry E Davis
Journal:  Curr Treat Options Neurol       Date:  2013-08       Impact factor: 3.598

5.  Invitro Activities of Polymyxins and Rifampicin against Carbapenem Resistant Acinetobacter baumannii at a Tertiary Care Hospital from South India.

Authors:  Dheepa Muthusamy; S Sudhishnaa; Appalaraju Boppe
Journal:  J Clin Diagn Res       Date:  2016-09-01

6.  Colistin administration to pediatric and neonatal patients.

Authors:  Elias Iosifidis; Charalampos Antachopoulos; Maria Ioannidou; Magda Mitroudi; Maria Sdougka; Vassiliki Drossou-Agakidou; Maria Tsivitanidou; Emmanuel Roilides
Journal:  Eur J Pediatr       Date:  2010-01-30       Impact factor: 3.183

7.  Acinetobacter baumannii: A Brief Account of Mechanisms of Multidrug Resistance and Current and Future Therapeutic Management.

Authors:  Harmanjit Singh; Pugazhenthan Thangaraj; Amitava Chakrabarti
Journal:  J Clin Diagn Res       Date:  2013-11-10

8.  Systematic review of invasive Acinetobacter infections in children.

Authors:  Jia Hu; Joan L Robinson
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

9.  Multidrug resistant acinetobacter.

Authors:  Vikas Manchanda; Sinha Sanchaita; Np Singh
Journal:  J Glob Infect Dis       Date:  2010-09

10.  Bacterial meningitis: epidemiology, pathogenesis and management update.

Authors:  Yuliya Nudelman; Allan R Tunkel
Journal:  Drugs       Date:  2009       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.